Are ‘mini-med’ program waivers a good idea? Several plans flunk of great benefit requirements stipulated in the new health law . Read the entire story. This article is definitely republished with kind authorization from our friends at The Kaiser Family Foundation. You will see the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, discussions and debates. The Daily Health Policy Report is released for Kaisernetwork.org, a free of charge support of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Table Kaiser and Company Family members Foundation. All rights reserved.Neither of the parties endorse or recommend any commercial products, services, or equipment.
CARLINA, Atlangram partner to develop antibiotics for osteoarticular infectious diseases CARLINA Technologies, a biotechnology company focusing on the development of nanomedicines, today announces the signing of a partnership agreement with Atlangram for the advancement of innovative pharmaceutical types of antibiotics for the targeting of osteoarticular infectious illnesses. In addition, the nanocapsule encapsulation decreases the chance of tissue irritation from the antibiotics, and increases the pharmacology of antibiotics they convey, including preventing bacterial resistance.